Posted by Michael Wonder on 24 Nov 2016
Promise of genetic sequencing frustrated by the cost of medicines for rare cancer patients
23 November 2016 - Ann Bantoft feels like she has been asked to put a price on her son's life - and she cannot afford it.
It is the price of a wonder drug that is the young man's last hope to defeat a tumour that has proved oblivious to radiation, indifferent to chemotherapy and too perilous for surgery - and it costs $8612 a month.
